Screening for prostate cancer may not reduce mortalityBMJ 2006; 332 doi: https://doi.org/10.1136/bmj.332.7533.72-g (Published 12 January 2006) Cite this as: BMJ 2006;332:72
- Fred Charatan
Screening tests using prostate specific antigen (PSA), with or without digital rectal examination, can increase the detection of cancer, even at early stages of the disease. However, they do not necessarily prolong survival. This is the conclusion of a study published this week in the Archives of Internal Medicine (2006;166:38-43).
John Concato and his team of 12 investigators identified 501 patients out of 71 661 patients at 10 Veterans Affairs medical centres in New England who were given a diagnosis of …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial